While most CXCL13+ T cells in breast cancer samples are CD4+ T cells, a subset of tumor-infiltrating CD8+ T cells was also noted to produce CXCL13 and reside near B cell follicles, albeit with lower CXCL13 expression than in CD4+ T cells [105]. This evidence concerns the gene CD4 and breast carcinoma.